# FDA Inspection 996830 - Biomat USA, Inc. - October 31, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e948ef64-390d-44c3-845a-82f4234792c8
Source feed: FDA_Inspections

> FDA Inspection 996830 for Biomat USA, Inc. on October 31, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 996830
- Company Name: Biomat USA, Inc.
- Inspection Date: 2016-10-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1166510 - 2022-03-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5bbec716-0c6b-46d4-abe9-3715d023a013)
- [FDA Inspection 1166510 - 2022-03-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/342b1a38-b39a-49a6-a640-92b6cc7c14e9)
- [FDA Inspection 1073794 - 2018-10-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ade3b074-5e1e-4672-9d49-f63693ed5a4e)
- [FDA Inspection 901811 - 2014-10-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f48a4388-561a-4ace-b667-12556ee650ad)
- [FDA Inspection 852533 - 2013-10-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1d1ee6a7-0718-455c-a117-7cbe2d400699)

Company: https://www.keypedia.com/companies/biomat-usa-inc/a823f72a-82ed-4e76-98f4-44154a8ad624

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d